Describing outcomes of PICALM at EHA24 - Sankalp Arora MD Anderson Cancer Center #Cancer #EHA24 #ExtramedullaryDisease #AcuteLeukemias #MLLT10 #OncoDaily #Oncology #PICALM
OncoDaily’s Post
More Relevant Posts
-
🌟 𝗡𝗲𝘄 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝗔𝗹𝗲𝗿𝘁: "𝗪𝗵𝗮𝘁’𝘀 𝗡𝗲𝘄 𝗗𝗼𝗰? 𝗶𝗻 𝗟𝘂𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿" 🌟 Professors Johan Vansteenkiste and Mariana Brandao presented findings from the AEGEAN trial, which delves into predictive biomarkers for treatment effectiveness in lung cancer. 👇 Watch all WND Lung videos - link in the comments! #MediMix #LungCancer #Immunotherapy #Oncology
To view or add a comment, sign in
-
FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer NEJM Group American Society of Clinical Oncology (ASCO) UCLA Health Sam S. Chang, MD MBA Gene Kramolowsky Mark Gonzalgo Jeffrey Bassett https://lnkd.in/dDdbhN8R #BladderCancer #Cancer #FDA #FDAApproval #Headlines #NonMuscleInvasiveBladderCancer #OncoDaily #Oncology #TransurethralResection #DrugDevelopment
To view or add a comment, sign in
-
🌟 𝗡𝗲𝘄 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝗔𝗹𝗲𝗿𝘁: "𝗪𝗵𝗮𝘁’𝘀 𝗡𝗲𝘄 𝗗𝗼𝗰? 𝗶𝗻 𝗟𝘂𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿" 🌟 Prof Johan Vansteenkiste (University Hospitals Leuven) and Prof Mariana Brandao (Institut Jules Bordet) reveal the long-awaited OS results from the ADAURA trial in the latest episode of 'What's New in Doc?' in Lung Cancer. 👇 Watch all WND Lung videos - link in the comments! #MediMix #LungCancer #Immunotherapy #Oncology #ADAURATrial #osimertinib
To view or add a comment, sign in
-
Our phase 2 trial of SG Pembro in platinum-resistant IO-naive 2L setting - Petros Grivas ECOG-ACRIN Cancer Research Group #Cancer #CancerResearch #JournalOfClinicalOncology #OncoDaily #Oncology
Petros Grivas: Our phase 2 trial of SG Pembro in platinum-resistant IO-naive 2L setting - OncoDaily
oncodaily.com
To view or add a comment, sign in
-
Important preliminary signal of transient response in GBM with CAR-T cells - Wafik S. El-Deiry, MD, PhD, FACP #Cancer #CancerResearch #Glioblastoma #OncoDaily #Oncology
Wafik S. El-Deiry: Important preliminary signal of transient response in GBM with CAR-T cells - OncoDaily
oncodaily.com
To view or add a comment, sign in
-
🌟 𝗡𝗲𝘄 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝗔𝗹𝗲𝗿𝘁: "𝗪𝗵𝗮𝘁’𝘀 𝗡𝗲𝘄 𝗗𝗼𝗰? 𝗶𝗻 𝗟𝘂𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿" 🌟 Don't miss this episode of WND in Lung Cancer trial by Prof Johan Vansteenkiste and Prof Mariana Brandao on the LIBRETTO-431, investigating selpercatinib's efficacy in RET fusion-positive NSCLC patients. 👇 Watch all WND Lung videos - link in the comments! #MediMix #LungCancer #Immunotherapy #Oncology
To view or add a comment, sign in
-
Metastatic lung adenocarcinoma with EGFR and TP53 co-mutations shows mixed intra-patient tumor responses Yüksel ÜRÜN Charles Swanton Cancer Research UK (CRUK) https://lnkd.in/eDgfQ-pw #SchoolofMedicine #Cancer #EGFR #EpidermalGrowthFactor #Adenocarcinoma #OncoDaily #Oncology
To view or add a comment, sign in
-
Discover how vMTBs are shaping the future of cancer care - Prof. Dr. Mutlu Demiray The Oncologist Journal Medicana Health Group #Cancer #CancerCaseStudies #OncoDaily #Oncology #PrecisionOncology #TheOncologist
Mutlu Demiray: Discover how vMTBs are shaping the future of cancer care - OncoDaily
oncodaily.com
To view or add a comment, sign in
-
A comprehensive review of ponatinib in CML and Ph ALL - Leukemia Department - Hagop Kantarjian, M.D. MD Anderson Cancer Center Fadi Haddad Nicholas Short Sanam Loghavi #Cancer #CML #AML #Leukemia #OncoDaily #Oncology
Hagop Kantarjian: A comprehensive review of ponatinib in CML and Ph ALL - OncoDaily
oncodaily.com
To view or add a comment, sign in
-
🌟 Submission Deadline Extended 🌟 📚Special Issue "Gastrointestinal Cancer: Outcomes and Therapeutic Management", hosted by Dr. Maximos Frountzas MD MPA PhD ⏰ New Submission Deadline: 28 February 2025 📢 Welcome to contribute and read the wonderful articles. 👇 https://lnkd.in/g4rHpsjq #Oncology #Cancer #Gastrointestinal Cancer #esophageal #gastric #colon #rectal #pancreatic Journal of Clinical Medicine (JCM) MDPI
To view or add a comment, sign in
25,576 followers